BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 12738750)

  • 21. Mutation(s) of the thymidylate synthase gene of human adenocarcinoma cells causes a thymidylate synthase-negative phenotype that can be attenuated by exogenous folates.
    Houghton PJ; Rahman A; Will CL; Dolnick BJ; Houghton JA
    Cancer Res; 1992 Feb; 52(3):558-65. PubMed ID: 1732043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BGC 945, a novel tumor-selective thymidylate synthase inhibitor targeted to alpha-folate receptor-overexpressing tumors.
    Gibbs DD; Theti DS; Wood N; Green M; Raynaud F; Valenti M; Forster MD; Mitchell F; Bavetsias V; Henderson E; Jackman AL
    Cancer Res; 2005 Dec; 65(24):11721-8. PubMed ID: 16357184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methotrexate (MTX) and albumin coupled with MTX (MTX-HSA) suppress synovial fibroblast invasion and cartilage degradation in vivo.
    Fiehn C; Neumann E; Wunder A; Krienke S; Gay S; Müller-Ladner U
    Ann Rheum Dis; 2004 Jul; 63(7):884-6. PubMed ID: 15194591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced antitumor activity of 5-fluorouracil in combination with 2'-deoxyinosine in human colorectal cell lines and human colon tumor xenografts.
    Ciccolini J; Peillard L; Evrard A; Cuq P; Aubert C; Pelegrin A; Formento P; Milano G; Catalin J
    Clin Cancer Res; 2000 Apr; 6(4):1529-35. PubMed ID: 10778986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel combination antimetabolite, TAS-102, exhibits antitumor activity in FU-resistant human cancer cells through a mechanism involving FTD incorporation in DNA.
    Emura T; Suzuki N; Yamaguchi M; Ohshimo H; Fukushima M
    Int J Oncol; 2004 Sep; 25(3):571-8. PubMed ID: 15289858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flavopiridol (L86-8275): selective antitumor activity in vitro and activity in vivo for prostate carcinoma cells.
    Drees M; Dengler WA; Roth T; Labonte H; Mayo J; Malspeis L; Grever M; Sausville EA; Fiebig HH
    Clin Cancer Res; 1997 Feb; 3(2):273-9. PubMed ID: 9815683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antitumor effect and mechanism of shikonin derivative SYUNZ-7].
    Huang H; Xie BF; Zhu XF; Feng GK; Zhou JM; Wang Y; Wu HQ; Huang ZS; Gu LQ; Liu ZC
    Ai Zheng; 2005 Dec; 24(12):1453-8. PubMed ID: 16351791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
    Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of Hsp90 inhibition for induction of apoptosis and inhibition of growth in cervical carcinoma cells in vitro and in vivo.
    Schwock J; Pham NA; Cao MP; Hedley DW
    Cancer Chemother Pharmacol; 2008 Apr; 61(4):669-81. PubMed ID: 17579866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo antitumor activity of camptothecin incorporated in liposomes formulated with an artificial lipid and human serum albumin.
    Watanabe M; Kawano K; Toma K; Hattori Y; Maitani Y
    J Control Release; 2008 May; 127(3):231-8. PubMed ID: 18384903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of cepharanthine alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
    Harada K; Ferdous T; Itashiki Y; Takii M; Mano T; Mori Y; Ueyama Y
    Anticancer Res; 2009 Apr; 29(4):1263-70. PubMed ID: 19414373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High level of stabilized angiostatin mediated by adenovirus delivery does not impair the growth of human neuroblastoma xenografts.
    Joseph JM; Bouquet C; Opolon P; Morizet J; Aubert G; Rössler J; Gross N; Griscelli F; Perricaudet M; Vassal G
    Cancer Gene Ther; 2003 Nov; 10(11):859-66. PubMed ID: 14605672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nature of linkage and mode of action of methotrexate conjugated with antitumor antibodies: implications for future preparation of conjugates.
    Endo N; Takeda Y; Umemoto N; Kishida K; Watanabe K; Saito M; Kato Y; Hara T
    Cancer Res; 1988 Jun; 48(12):3330-5. PubMed ID: 3259466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of thymidylate synthase (TS) protein up-regulation after exposure to TS inhibitors in normal and tumor cell lines and tissues.
    Welsh SJ; Titley J; Brunton L; Valenti M; Monaghan P; Jackman AL; Aherne GW
    Clin Cancer Res; 2000 Jun; 6(6):2538-46. PubMed ID: 10873110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serine/threonine protein phosphatase inhibition enhances the effect of thymidylate synthase inhibition.
    Sakoff JA; Howitt IJ; Ackland SP; McCluskey A
    Cancer Chemother Pharmacol; 2004 Mar; 53(3):225-32. PubMed ID: 14648018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Preparation and cytotoxicity of McAb-HSA-MTX conjugates].
    Yin Z
    Zhonghua Yi Xue Za Zhi; 1990 Oct; 70(10):556-9, 40. PubMed ID: 2176564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of 2-methoxyestradiol and methotrexate effects on non-Hodgkin's B-cell lymphoma.
    Park J; Franco RS; Augsburger JJ; Banerjee RK
    Curr Eye Res; 2007; 32(7-8):659-67. PubMed ID: 17852190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antitumor effects and normal tissue toxicity of 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts.
    Chen P; Cameron R; Wang J; Vallis KA; Reilly RM
    J Nucl Med; 2003 Sep; 44(9):1469-78. PubMed ID: 12960194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The synthetic compound CC-5079 is a potent inhibitor of tubulin polymerization and tumor necrosis factor-alpha production with antitumor activity.
    Zhang LH; Wu L; Raymon HK; Chen RS; Corral L; Shirley MA; Narla RK; Gamez J; Muller GW; Stirling DI; Bartlett JB; Schafer PH; Payvandi F
    Cancer Res; 2006 Jan; 66(2):951-9. PubMed ID: 16424030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trastuzumab decorated methotrexate-human serum albumin conjugated nanoparticles for targeted delivery to HER2 positive tumor cells.
    Taheri A; Dinarvand R; Atyabi F; Ghahremani MH; Ostad SN
    Eur J Pharm Sci; 2012 Sep; 47(2):331-40. PubMed ID: 22771547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.